Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates

This study has been completed.

Study NCT00066989 Information provided by Nabi Biopharmaceuticals

First Received: August 8, 2003 Last Updated: July 11, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given